NATCO transfers Lenalidomide ANDA to Arrow

NATCO transfers Lenalidomide ANDA to Arrow

by admin- Wednesday, August 4th, 2021 04:01:07 PM

Natco Pharma has transferred the Lenalidomide Capsules ANDA to Arrow International Ltd as per an earlier settlement among the parties.

This transfer of the ANDA to Arrow does not materially trade any of the phrases of the agreement among the parties.

Arrow International is the marketing associate of NATCO forth is product in the US market. The ANDA become approved by using USFDA in May 2021 with final approval in the Smg, lOmg, lSmg, and 25mg strengths, and tentative approval in the 2.Smg and 20mg strengths.

News Updates